Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluated
Saved in:
| Main Authors: | Christophe Richez, Stanislas Faguer, Noémie Jourde-Chiche, Eric Daugas, Ludivine Lebourg, Sébastien Boutinet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/1/e001509.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune characterization of lupus nephritis patients undergoing dialysisKey messages
by: Quentin Simon, et al.
Published: (2025-06-01) -
Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease
by: Benoît Brilland, et al.
Published: (2025-04-01) -
The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
by: Laurent Chiche, et al.
Published: (2012-01-01) -
WCN24-1487 Evaluation of the remission of lupus nephritis with induction immunosuppressive treatment in an Ecuadorian population
by: María José Cajas, et al.
Published: (2024-04-01) -
Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis
by: Javier Narváez, et al.
Published: (2025-01-01)